☆ 4.3 Editorial Material

Risk versus benefit or risk versus risk: Risk aversion in the medical decision making process

JOURNAL OF DERMATOLOGICAL TREATMENT (2017)

Get Full Text
Add to Collection

Journal

JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 28, Issue 1, Pages 1-2

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09546634.2017.1290575

Keywords

-

Categories

Dermatology

Funding

  1. Galderma
  2. GSK/Stiefel
  3. Almirall
  4. Leo Pharma
  5. Baxter
  6. Boeringer Ingelheim
  7. Mylan
  8. Celgene
  9. Pfizer
  10. Valeant
  11. Abbvie
  12. Cosmederm
  13. Anacor
  14. Astellas
  15. Janssen
  16. Lilly
  17. Merck
  18. Merz
  19. Novartis
  20. Qurient
  21. National Biological Corporation
  22. Caremark
  23. Advance Medical
  24. Suncare Research
  25. Informa
  26. UpToDate
  27. National Psoriasis Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.